Opioid maker Collegium buys N.C. competitor for $604M
February 14, 2022 at 12:18 PM EST
The Stoughton drug company is shelling out $604 million to buy a Raleigh, N.C.-based competitor called BioDelivery Sciences International Inc.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|